Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.


Accelerate study start-up and amendments, simplify site and sponsor experience, reduce trial supply costs and improve study decision making while ensuring quality standards and patient safety during your trial with IQVIA Interactive Response Technology. Built on a robust, scalable platform, our patient-centric approach to technology delivery provides exceptional value and peace of mind for sponsors and their patients in clinical trials.
IQVIA IRT is part of the Digital Patient Suite of IQVIA Technologies Orchestrated Clinical Trials (OCT), an end-to-end, patient centric platform that provides an unparalleled data infrastructure, seamless connectivity and intuitive design to drive smarter, faster trials.
Ensure compliance with independent UAT for Good Practices (GxP)
Operational trial data from any CRO and any trial at your fingertips
Published on Technology Networks Drug Discovery
Insights into IQVIA's CDAS framework
Harnessing the power of AI to orchestrate improved outcomes across the clinical trial landscape
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.